Haleon

Haleon plc
Company typePublic limited company
ISINGB00BMX86B70
Industry
Predecessors
Founded18 July 2022; 3 years ago (2022-07-18)
HeadquartersWeybridge, England, United Kingdom
Area served
Worldwide
Key people
Products
Brands
RevenueDecrease £11,030 million (2025)[1]
Increase £2,412 million (2025)[1]
Increase £1,680 million (2025)[1]
Total assetsDecrease £32,630 million (2025)[1]
Total equityIncrease £16,484 million (2025)[1]
Number of employees
24,000 (2024)[2]
SubsidiariesHaleon Pakistan
Websitewww.haleon.com

Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England.[3] It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins.[4] The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.[5]

Haleon was established on 18 July 2022 as a corporate spin-off from GSK.[6] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange.

History

GSK and Pfizer merged their consumer healthcare businesses in 2019.[7][8] GSK owned just over two thirds of the joint venture, and Pfizer owned the remainder.[7] Annual sales were around £10 billion across 120 markets in 2020.[5]

GSK announced plans to spin off Haleon in 2022 to give the "tired drugmaker extra focus and firepower by gearing up and hiving off the consumer division," according to Reuters.[9]

Unilever offered £50 billion for the business in 2022, which GSK rejected.[10] Nestlé examined the possibility of a bid in conjunction with Reckitt.[11]

In October 2023, GSK reduced its ownership in Haleon to 7.4%,[12] and in January 2024 it further reduced its ownership to 4.2%.[13]

in August 2023, Haleon sold its Lamisil antifungal brand to Karo Healthcare AB for £235 million.[14][15]

In February 2024, Haleon sold its ChapStick lip care brand to Yellow Wood Partners for £401 million.[16]

In March 2024, Pfizer reduced its share in Haleon from 32% to 24% per cent by selling 630 million shares in a public offering.[17]

In April 2024, Haleon announced that it would close its Sensodyne toothpaste factory in Maidenhead,[18] moving that manufacturing to Slovakia, and it outsourced mouthwash manufacturing to an unrelated company.[19]

In September 2024, the company completed the sale of its non-US nicotine replacement therapy business to Dr. Reddy's Laboratories in a deal worth £458 million.[20]

In March 2025, Pfizer sold its entire stake in Haleon for £2.5 billion ($3.24 billion), exiting the consumer healthcare business it helped create by its 2019 joint venture with GSK.[21][22][23]

Operations

Oral health accounted for 28.5 percent of revenue in 2021.[24]

Sir Dave Lewis is chairman, with Brian McNamara as chief executive.[25]

Brands

A selection of Aquafresh toothpaste and toothbrushes produced by Haleon

Current

Brands include:[26]

  • Abreva (Docosanol)
  • Advil (Ibuprofen)
  • alli (Orlistat)
  • Anadin (pain relief)
  • Aquafresh (oral healthcare)
  • Astring-o-Sol (oral healthcare)
  • Be-Total (leader in vitamins market in Italy)
  • Beechams Cold & Flu and Night/Day Nurse (cold and flu treatments)
  • Biotene (oral healthcare)
  • Boost (nutritional)
  • Breathe Right (respiratory)
  • Calpol (fever medicine)
  • Caltrate (bone and joint supplement)
  • Centrum (vitamins and naturals)
  • Cetebe (vitamins and naturals)
  • Chlorhexamed (oral healthcare)
  • Cholinex (analgesics and respiratory tract)
  • Citrucel (gastrointestinal)
  • Clusivol (multivitamins)
  • Coldrex (cold and flu treatment)
  • Commit Lozenge (smoking cessation)
  • Committed Quitters (nicotine replacement)
  • Corega (oral healthcare)
  • Corsodyl (oral healthcare)
  • Crocin (analgesics and respiratory tract)
  • Dr. Best (oral healthcare)
  • Emergen-C
  • ENO (gastrointestinal)
  • Eroxon
  • Eumovate (dermatological)
  • Excedrin
  • Fenistil
  • Fenbid (analgesics and respiratory tract)
  • Fibrosine (constipation relief)
  • Flonase (fluticasone propionate)
  • Foodles (noodles), origin: India
  • Formigran (analgesic/triptan)
  • Grand-PA (headache/toothache/pain and fever)
  • Hinds (dermatological)
  • Imedeen
  • Iodex (pain relief)
  • Iodosan (cold and flu treatment)
  • Junior Horlicks (nutritional)
  • Loviscol (cough suppressant)
  • Macleans (oral healthcare)
  • Maltova (nutritional)
  • Maxinutrition (nutritional)
  • Med-Lemon (hot, cold and flu medication)
  • Medacalm (vitamins and naturals)
  • Nexium Control (esomeprazole)
  • Nicorette (nicotine replacement)
  • Night Nurse (cold and flu remedy)
  • NiQuitin CQ/ Nicoderm CQ/ Nicabate (nicotine replacement)
  • Odol (oral healthcare)
  • Odol-med3 (oral healthcare)
  • Os-cal (vitamins and minerals)
  • Otrivin/Otrivine (xylometazoline)
  • Panadeine (analgesics and respiratory tract)
  • Panadol/Panodil (analgesics and respiratory tract)
  • Parodontax (oral healthcare)
  • Piriton/Piriteze/Pirinase (anti-allergy)
  • Polident (oral healthcare)
  • Poligrip Ultra (oral healthcare)
  • Robikids (kids’ cough medicine)
  • Robitussin (respiratory medicine)
  • Rutinoscorbin (vitamins and naturals)
  • Scott's (vitamins and naturals)
  • Sensodyne (oral healthcare)
  • Shumitect (oral healthcare)
  • Simeco (gastrointestinal)
  • Sinecod (cough medicine)
  • Solpadeine (analgesics and respiratory tract)
  • Stresstabs (stress reliever)
  • Super Poligrip (oral healthcare)
  • Super Wernet's (oral healthcare)
  • Synthol (oral healthcare)
  • Theraflu (Respiratory)
  • TriHEMIC (anemia medicine)
  • Tums (gastrointestinal)
  • Viva (vitamins and naturals), origin: Nepal
  • Voltaren/Voltarol (anti inflammatory)
  • Zovirax (dermatological)

Divested

  • ChapStick (sold to Yellow Wood Partners in 2024)
  • Lamisil (terbinafine) (sold to Karo Healthcare in 2023)
  • Nicotinell (sold to Dr Reddy's Laboratories in 2024)

References

  1. ^ a b c d e "Annual results 2025" (PDF). Haleon. Retrieved 25 February 2026.
  2. ^ "Sensodyne-maker Haleon to shut UK plant, 435 jobs to go". Reuters. 30 April 2024. Retrieved 9 February 2025.
  3. ^ "GSK announces independent Consumer Healthcare company is to be called Haleon". www.gsk.com. 22 February 2022. Archived from the original on 21 February 2023. Retrieved 21 February 2023.
  4. ^ Ralph, Alex (2 July 2022). "GlaxoSmithKline prepares to get back to basics with historic break-up". The Times. Archived from the original on 5 August 2023. Retrieved 4 July 2022.
  5. ^ a b Cornell, Joe (15 July 2021). "GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022". Forbes. Archived from the original on 11 February 2023. Retrieved 10 June 2022.
  6. ^ "Prospectus" (PDF). GSK plc. p. 15. Archived from the original (PDF) on 1 June 2022. Retrieved 10 June 2022.
  7. ^ a b Shane, Daniel (19 December 2018). "Advil meet Excedrin: Pfizer and GSK are merging their consumer healthcare businesses". CNN. Archived from the original on 6 June 2023. Retrieved 10 June 2022.
  8. ^ "Haleon Won't Indemnify Pfizer, GSK Over Zantac. Shares Are Up". Barron's. 20 September 2022. Archived from the original on 10 November 2022. Retrieved 17 December 2022.
  9. ^ Donnellan, Aimee (9 June 2022). "GSK castoff starts life with target on its back". Reuters. Archived from the original on 22 September 2022. Retrieved 10 June 2022.
  10. ^ Jolly, Jasper (19 January 2022). "Unilever will not increase £50bn offer for GSK consumer arm". The Guardian. Archived from the original on 18 October 2022. Retrieved 10 June 2022.
  11. ^ "Nestle Eyed Biggest-Ever Deal in Aborted Move for GSK Unit". Bloomberg News. 25 May 2022. Archived from the original on 30 April 2023. Retrieved 10 June 2022.
  12. ^ "GSK raises $1.1 billion from Haleon stake sale". Reuters. 6 October 2023. Archived from the original on 7 October 2023. Retrieved 9 October 2023.
  13. ^ "GSK raises $1.24 bln from latest Haleon stake sale". Reuters. 17 January 2024. Retrieved 18 January 2024.
  14. ^ "Karo Healthcare acquires the Global OTC brand Lamisil® from Haleon". Karo Healthcare. 2 August 2023. Archived from the original on 5 June 2024. Retrieved 5 June 2024.
  15. ^ "Karo Healthcare completes the acquisition of the rights to the Global OTC brand Lamisil® from Haleon". Karo Healthcare. 1 November 2023. Archived from the original on 5 June 2024. Retrieved 5 June 2024.
  16. ^ Williams, Holly (25 January 2024). "Haleon offloads ChapStick lip balm brand in £401m deal". The Standard. Archived from the original on 20 February 2024. Retrieved 20 February 2024.
  17. ^ "Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%". Yahoo Finance. 18 March 2024. Archived from the original on 19 March 2024. Retrieved 19 March 2024.
  18. ^ Briant, Nathan (30 April 2024). "Sensodyne maker set to cut 435 jobs". BBC News. Archived from the original on 8 May 2024. Retrieved 8 May 2024.
  19. ^ Mathews, Eva (30 April 2024). "Sensodyne-maker Haleon to shut UK plant, 435 jobs to go". Reuters. Retrieved 8 May 2024.
  20. ^ "Dr Reddy's Laboratories completes acquisition of Haleon's NRT portfolio". Press Trust of India. Business Standard. 30 September 2024. Archived from the original on 29 October 2024. Retrieved 25 November 2024.
  21. ^ "Pfizer sells entire Haleon stake for $3.24 billion". Reuters.
  22. ^ "Pfizer sells entire Haleon stake for £2.5 billion". 19 March 2025.
  23. ^ "Pfizer offloads Haleon shares in $3.24 billion deal". Profit by Pakistan Today. 19 March 2025. Retrieved 20 March 2025.
  24. ^ "Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon". GSK. 6 January 2022. Archived from the original on 29 March 2023. Retrieved 10 June 2022.
  25. ^ Kleinman, Mark (3 May 2022). "GSK's £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks". Sky News. Archived from the original on 11 February 2023. Retrieved 10 June 2022.
  26. ^ "Our Consumer Healthcare Brands". Haleon. Archived from the original on 2 August 2023. Retrieved 19 July 2022.
allikas: https://en.wikipedia.org/wiki/Odol